Isolation, identification and determination of the major degradation product in alprazolam tablets during their stability assay

Journal of Pharmaceutical and Biomedical Analysis

Volumn 44, Issue 2, 2007, Pages 404-413

  Huidobro, A L ^a   Ruperez F J ^a   Barbas, C ^a  

^a UNIVERSIDAD SAN PABLO CEU   (Spain)

Author keywords

Alprazolam; Impurity identification; Stress test; Triazolaminoquinoleine

Indexed keywords

ALPRAZOLAM; QUINOLINE DERIVATIVE; TRIAZOLAMINOQUINOLEINE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DRUG DEGRADATION; DRUG DETERMINATION; DRUG IDENTIFICATION; DRUG IMPURITY; DRUG ISOLATION; DRUG STABILITY; HEAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMIDITY; INFRARED RADIATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET RADIATION;

ALPRAZOLAM; ANTI-ANXIETY AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG CONTAMINATION; DRUG STABILITY; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; QUINOLINES; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SOLID PHASE EXTRACTION; SPECTROPHOTOMETRY, INFRARED; SPECTROPHOTOMETRY, ULTRAVIOLET; TABLETS;

EID: 34249948241     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2006.12.003     Document Type: Article

References (12)

1. International Conferences on Harmonization of the Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Impurities in New Drug Substances, Q3A(R) Federal Register January 1996, 1996.
2. Verster J.C., and Volkerts E.R. CNS Drug Rev. 10 (2004) 45-76
3. Perez-Lozano P., Garcia-Montoya E., Orriols A., Minarro M., Tico J.R., and Sune-Negre J.M. J. Pharm. Biomed. Anal. 34 (2004) 979-987
4. Nudelman N.S., and Cabrera C.G. J. Pharm. Sci. 91 (2002) 1274-1286
5. EURACHEM Guidance, Guide 25, 1993.
6. Marin A., Espada A., Vidal P., and Barbas C. Anal. Chem. 77 (2005) 471-477
7. Alsante K.M., Boutros P., Couturier M.A., Friedmann R.C., Harwood J.W., Horan G.J., Jensen A.J., Liu Q., Lohr L.L., Morris R., Raggon J.W., Reid G.L., Santafianos D.P., Sharp T.R., Tucker J.L., and Wilcox G.E. J. Pharm. Sci. 93 (2004) 2296-2309
8. Saavedra L., Huidobro A., García A., Cabanelas J., González M., and Barbas C. Electrophoresis 27 (2006) 2360-2366
9. ICH, ICH Harmonised Tripartite Guideline, vol. Step 1, Ch. Draft §8, 1995, p. 1.
10. ICH, ICH Harmonised Tripartite Guideline, vol. Step 4, Ch. Consensus Guideline, 1996.
11. ICH, ICH Harmonised Tripartite Guideline, vol. Step 3, Ch. Consensus Guideline, 1996.
12. ICH, ICH Harmonised Tripartite Guideline ICH topic Q2B, 1996.